Latest Peplin news



news 

01-Feb-10

LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition read more

21-Dec-09

Positive Results for LEO Pharma's Phase III Actinic Keratosis Trials on the Face and Scalp read more

12-Nov-09

Letter to our CDI Holders read more


›› More News
click here to download the Adobe reader

ASX and media 2006 releases

Recent year | Archived 2006 | Archived 2005 | Archived 2004 | Archived 2003 | Archived 2002

Archived 2006

29-11-2006 PEP005's novel anti-skin cancer mechanism published 23 kb
06-11-2006 Peplin to present at Rodman & Renshaw 8th Annual Healthcare Conference 294 kb
01-11-2006 Peplin announces completion of international financing 20 kb
30-10-2006 Peplin to operation manufacturing plant 21 kb
12-10-2006 Results of Annual General Meeting 26 kb
12-10-2006 Chairman's address to Annual General Meeting 250 kb
12-10-2006 Peplin announces completion of enrollment in SCC pilot clinical trial 20 kb
11-10-2006 Peplin announces satisfaction of pre-conditions to second tranche 20 kb
09-10-2006 Peplin takes steps to secure manufacturing plant 19 kb
11-09-2006 Peplin appoints Chief Financial Officer 21 kb
08-08-2006 Results for the financial year ended 30 June 2006 24 kb
01-08-2006 Details of phase IIb actinic keratosis trial 28 kb
20-07-2006 Peplin celebrates the opening of its new GMP manufacturing facility 22 kb
17-07-2006 Peplin announces results of nodular basal cell carcinoma (nBCC) clinical trial 36 kb
04-07-2006 Entitlement offer closes 26 kb
26-06-2006 Results of General Meeting 26 kb
24-06-2006 Chairman's and Managing Director's address to General Meeting 70 kb
22-06-2006 Peplin to appoint Eugene Bauer M.D. to board 27 kb
15-06-2006 Peplin establishes US operations and enhances product development team 45 kb
30-05-2006 Notice of General Meeting 24 June 2006 126 kb
24-05-2006 Peplin announces major international capital raising 51 kb
22-05-2006 Start of new skin cancer clinical trial 28 kb
11-05-2006 Initiation of standard safety study 25 kb
09-05-2006 Peplin announces further positive results of its US phase IIa AK trial 39 kb
01-05-2006 Peplin announces positive results of phase IIa skin cancer trial 57 kb
11-04-2006 Company Secretary appointed 27 kb
28-03-2006 Peplin Corporate Strategy 28 kb
28-02-2006 CFO resigns 26 kb
28-02-2006 Completion of enrolment for the nBCC clinical trial 42 kb
27-02-2006 Results of US dose escalation clinical trial 33 Kb
07-02-2006 Peplin First Half Results 55 Kb
13-02-2006 Peplin to present at BIO CEO & Investor Conference 2006 30 Kb